Gtp

Gtp

SCHEMBL103832

Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2O)c(=O)[nH]1

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 1/20 0.81
NT5E P21589 1/20 0.76
KRAS P01116 2/20 0.76
FUT5 Q11128 1/20 0.75
P2RX3 P56373 2/20 0.71
P2RY6 Q15077 2/20 0.71
P2RY2 P41231 1/20 0.71
P2RY4 P51582 1/20 0.71
P2RY1 P47900 4/20 0.68
ENPP1 P22413 2/20 0.68
P2RX1 P51575 1/20 0.68
P2RY11 Q96G91 1/20 0.68
P2RX4 Q99571 1/20 0.68
P2RY12 Q9H244 1/20 0.66
IMPDH2 P12268 5/20 0.65
IMPDH1 P20839 1/20 0.65
DCPS Q96C86 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gtp SCHEMBL18271799 1.00 TGM2 (0.81) TGM2NT5EKRASFUT5P2RX3
Gtp SCHEMBL3333959 1.00 TGM2 (0.81) TGM2NT5EKRASFUT5P2RX3
SCHEMBL376140 1.00 TGM2 (0.81) TGM2NT5EKRASFUT5P2RX3
Gtp SCHEMBL18784960 1.00 TGM2 (0.81) TGM2NT5EKRASFUT5P2RX3
SCHEMBL376139 1.00 TGM2 (0.81) TGM2NT5EKRASFUT5P2RX3
SCHEMBL1304258 1.00 TGM2 (0.81) TGM2NT5EKRASFUT5P2RX3
SCHEMBL19691775 1.00 TGM2 (0.81) TGM2NT5EKRASFUT5P2RX3
SCHEMBL2593095 1.00 TGM2 (0.81) TGM2NT5EKRASFUT5P2RX3
Gtp SCHEMBL5809658 1.00 TGM2 (0.81) TGM2NT5EKRASFUT5P2RX3
Gtp SCHEMBL17367368 1.00 TGM2 (0.81) TGM2NT5EKRASFUT5P2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2168 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051816-A1 SINGLE-POT METHODS FOR PRODUCING CIRCULAR RNAS PEKING UNIVERSITY (CN) 2025-02-13 US claimed
WO-2024239431-A1 METHOD FOR PHOSPHORYLATION OF NUCLEIC ACID AT 3' END AND LIBRARY CONSTRUCTION 深圳华大智造科技股份有限公司 2024-11-28 WO claimed
US-20240158754-A1 REDUCING HIGH MANNOSE GLYCAN PROTEIN EXPRESSION USING GUANOSINE 5'-MONOPHOSPHATE MERCK SHARP & DOHME LLC (US) 2024-05-16 US claimed
US-20240076803-A1 Method for Library Preparation in Next Generation Sequencing by Enzymatic DNA Fragmentation Miltenyi Biotec B.V. & Co. KG (DE) 2024-03-07 US claimed
CN-117399072-A Ultra-small cerium-based metal organic framework nano enzyme and preparation method and application thereof 华南理工大学 2024-01-16 CN claimed
CN-116970614-A Compositions and methods for ribonucleic acid vaccines encoding NY-ESO-1 达冕疫苗(广州)有限公司 2023-10-31 CN claimed
WO-2023115732-A1 SINGLE-POT METHODS FOR PRODUCING CIRCULAR RNAS PEKING UNIVERSITY (CN) 2023-06-29 WO claimed
CN-113624862-B Metabolome covering multiple metabolites, metabolic flux analysis method and kit 清华大学 2023-04-07 CN claimed
WO-2022192055-A1 REDUCING HIGH MANNOSE GLYCAN PROTEIN EXPRESSION USING GUANOSINE 5'-MONOPHOSPHATE MERCK SHARP & DOHME LLC (US) 2022-09-15 WO claimed
EP-4036248-A1 METHOD FOR LIBRARY PREPARATION IN NEXT GENERATION SEQUENCING BY ENZYMATIC DNA FRAGMENTATION Miltenyi Biotec B.V. & Co. KG (DE) 2022-08-03 EP claimed
EP-1076096-A1 Process for producing GDP-fucose KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-02-14 EP claimed
WO-2000050642-A1 SEQUENCING BY INCORPORATION CALIPER TECHNOLOGIES CORP. (US) 2000-08-31 WO claimed
US-6103487-A DETECTING MODULATORS THAT SUPPRESS THE ACTIVITY OF A TRANSFERASES; ANTICARCINOGENIC AGENTS MERCK & CO., INC. (US) 2000-08-15 US claimed
EP-1019530-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 2000-07-19 EP claimed
EP-1009854-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 2000-06-21 EP claimed
US-6063400-A CARRIER; DIAGNOSTIC OR THERAPEUTIC AGENT AND SEQUESTERING AGENT SDG, INC. (US) 2000-05-16 US claimed
WO-1999010524-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1999-03-04 WO claimed
WO-1999010523-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1999-03-04 WO claimed
US-5741635-A DETERMINATION OF RAS-BOUND GTP LEVELS USEFUL AS A SCREENING METHOD FOR REGULATION OF G PROTEIN ACTIVATION IN MAMMALIAN CELLS AND TISSUES MOUNT SINAI HOSPITAL CORPORATION (CA) 1998-04-21 US claimed
US-4959212-A ENZYMES AND COENZYMES STANCESCO ALEXANDRA (US) 1990-09-25 US claimed